Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
MaSuRCA installation error
Hi
I was working on RNA sequence analysis of paired end sequence reads with Tuxedo pipeline. It required an additional installation of MaSuRCA genome assembler for assembling super reads. I downloaded the latest version, MaSuRCA-3.2.2_RC1 , and gave the following command in the MaSuRCA-3.2.2_RC1 directory for its installation.
# sudo ./install.sh
Since its a long output i have pasted it in paste bin and here is the corresponding pastebin link:
Pastebin.com is the number one paste tool since 2002. Pastebin is a website where you can store text online for a set period of time.
Due to the errors in between sr_config_example.txt file was not generated in MaSuRCA directory, and I couldn’t successfully run the perl command for assembling super reads. What could possibily be wrong here? Thanks in advance.
Febin@GC
Latest Articles
Collapse
-
by seqadmin
The complexity of cancer is clearly demonstrated in the diverse ecosystem of the tumor microenvironment (TME). The TME is made up of numerous cell types and its development begins with the changes that happen during oncogenesis. “Genomic mutations, copy number changes, epigenetic alterations, and alternative gene expression occur to varying degrees within the affected tumor cells,” explained Andrea O’Hara, Ph.D., Strategic Technical Specialist at Azenta. “As...-
Channel: Articles
07-08-2024, 03:19 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 07-25-2024, 06:46 AM
|
0 responses
9 views
0 likes
|
Last Post
by seqadmin
07-25-2024, 06:46 AM
|
||
Started by seqadmin, 07-24-2024, 11:09 AM
|
0 responses
26 views
0 likes
|
Last Post
by seqadmin
07-24-2024, 11:09 AM
|
||
Started by seqadmin, 07-19-2024, 07:20 AM
|
0 responses
160 views
0 likes
|
Last Post
by seqadmin
07-19-2024, 07:20 AM
|
||
Started by seqadmin, 07-16-2024, 05:49 AM
|
0 responses
127 views
0 likes
|
Last Post
by seqadmin
07-16-2024, 05:49 AM
|
Leave a comment: